Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SaiLuoTong in Vascular Dementia
NCT03789760Phase 3Completed
- Sponsor
- China Shenwei Pharmaceutical Group
- Start
- Apr 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
A Phase 3 trial of sailuotong in vascular dementia, sponsored by China Shenwei Pharmaceutical Group. Started Apr 2019; status: completed.
02
Drugs
sailuotong
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT03789760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789760.